Text Size

Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer

This study has been terminated.
Sponsor:
Collaborator:
Varian Medical Systems
Information provided by (Responsible Party):
Quynh-Thu Le, Stanford University
ClinicalTrials.gov Identifier:
NCT01011842
First received: November 9, 2009
Last updated: April 6, 2012
Last verified: April 2012
History of Changes

November 9, 2009
April 6, 2012
October 2009
March 2010   (final data collection date for primary outcome measure)
We are measuring how much a patient moves during treatment. [ Time Frame: This information will be available immediately have the patient is treated. ] [ Designated as safety issue: No ]
How much a patient moves during treatment. [ Time Frame: immediately after the patient is treated. ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT01011842 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer
Comparison of Intrafraction Motion in Patients With Head and Neck Cancer Using Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking

To determine if a new optical system that can track a patient's movement during treatment can be used to measure motion and allow for motion adjustments in order to decrease the amount of healthy tissue that receives radiation without limiting our ability to cure cancers using radiation.
Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Head and Neck Cancer
  • Procedure: Radiotherapy
    Standard of care
    Other Names:
    • Radiation therapy
    • radiation oncology
  • Procedure: Align RT
    Standard of care
    Other Name: Image-Guided Radiation Therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
11
November 2011
March 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with HNC undergoing radiation therapy at Stanford University
  • Age >= 18 years old
  • Radiation course >= 4 weeks duration
  • Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

  • Factors such as claustrophobia inhibiting use of thermoplastic mask immobilization device.
  • Patients who are pregnant or nursing, which preclude them from undergoing active radiation treatment.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01011842
ENT0028, SU-09082009-3800
Yes
Quynh-Thu Le, Stanford University
Stanford University
Varian Medical Systems
Principal Investigator: Quynh-Thu Le Stanford University
Stanford University
April 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP